Xencor Inc (XNCR)
19.85
+0.37
(+1.90%)
USD |
NASDAQ |
Oct 04, 16:00
19.85
0.00 (0.00%)
After-Hours: 20:00
Xencor Shareholders Equity (Annual): 668.80M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 668.80M |
| December 31, 2022 | 727.50M |
| December 31, 2021 | 733.50M |
| December 31, 2020 | 572.44M |
| December 31, 2019 | 593.20M |
| December 31, 2018 | 521.68M |
| December 31, 2017 | 316.46M |
| Date | Value |
|---|---|
| December 31, 2016 | 313.95M |
| December 31, 2015 | 162.43M |
| December 31, 2014 | 59.29M |
| December 31, 2013 | 73.53M |
| December 31, 2012 | -19.50M |
| December 31, 2011 | -10.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
572.44M
Minimum
2020
733.50M
Maximum
2021
659.09M
Average
668.80M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| Dynavax Technologies Corp | 622.07M |
| SINTX Technologies Inc | 8.772M |
| Fulcrum Therapeutics Inc | 235.19M |
| Moderna Inc | 13.85B |